CROI 2025: The Challenges of Sustaining Viral Suppression, Addressing Advanced HIV Disease, and Ending the HIV Epidemic Targets [0.03%]
CROI 2025：持续病毒抑制、应对晚期艾滋病病情以及实现终结艾滋病流行目标所面临的挑战
Shauna H Gunaratne,Hong-Van Tieu,Timothy J Wilkin et al.
Shauna H Gunaratne et al.
Important new data were presented at the 2025 Conference on Retroviruses and Opportunistic Infections. Mathematic models predicted a reversal of progress toward Ending the HIV Epidemic metrics if funding is discontinued. Interventions that ...
Sudipa Sarkar,Todd T Brown
Sudipa Sarkar
Aging-related comorbid conditions have major effects on health, quality of life, and survival in people with HIV (PWH). The 2025 Conference on Retroviruses and Opportunistic Infections (CROI) featured numerous studies about comorbid disease...
Annukka A R Antar,Michael J Peluso
Annukka A R Antar
New research on acute and postacute COVID-19 was presented at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI). Results of the SCORPIO-PEP (Stopping COVID-19 Progression With Early Protease Inhibitor Treatment-Postexp...
CROI 2025: global epidemiology and prevention of HIV and other sexually transmitted diseases [0.03%]
2025 CROI：HIV及其他性传播疾病的全球流行病学和预防
Susan P Buchbinder,Albert Y Liu
Susan P Buchbinder
At the 2025 Conference on Retroviruses and Opportunistic Infections (CROI), investigators presented updates on the global HIV epidemic. Although new HIV infections have been declining globally, new infections are expanding in Eastern Europe...
CROI 2025: tuberculosis, Mpox, and other infectious complications in people with HIV [0.03%]
2025年CROI会议：HIV患者中的结核病、马波斯痘和其他感染并发症
Andrew D Kerkhoff,Jason Zucker,Diane V Havlir
Andrew D Kerkhoff
Updated strategies and new insights into tuberculosis and mpox treatment were a major focus at the 2025 Conference on Retroviruses and Opportunistic Infections, headlined by findings that high-dose rifampicin plus levofloxacin increased ear...
Michael J Corley,Phillip Chan,Sarah B Joseph
Michael J Corley
The 2025 Conference on Retroviruses and Opportunistic Infections (CROI) showcased advances in understanding neuropsychiatric complications among people with HIV (PWH). This review synthesizes key findings related to central nervous system (...
Kenneth E Sherman,Phyllis C Tien,David L Thomas
Kenneth E Sherman
Liver disease remains a key contributor to morbidity and mortality among people with HIV. Although substantial progress has been made in terms of a cure for hepatitis C, increased life expectancy is associated with emerging issues associate...
Annemarie M Wensing,Vincent Calvez,Francesca Ceccherini-Silberstein et al.
Annemarie M Wensing et al.
Certain mutations in HIV-1 that emerge during exposure to antiretroviral drugs may have varied impact on the effectiveness of current and subsequent treatments for HIV. This 2025 edition of the International Antiviral Society-USA (IAS-USA) ...